Shubman Gill Undergoes Injection for Nerve Issue, Set to Miss Remainder of Season: Report

India Test and ODI captain Shubman Gill may have to wait a few months before he can return to action. He has a neck injury that is said to be more serious than it looked at first. Gill seemed to worsen the injury while batting on Day 2 of the first Test between India and South Africa in Kolkata. He faced only three balls before he was retired hurt. After that, he was taken on a stretcher to a local hospital. He stayed there for one day for observation and was then discharged.

Now, several reports say that Gill may miss the rest of 2025 because he has a nerve injury. He has been given an injection to help reduce the symptoms.

The 26-year-old left the Kolkata hospital wearing a neck brace. He still travelled to Guwahati with the India Test squad for the second match that started on Saturday morning. However, he was not selected in the playing XI, as he was ruled out on the eve of the match.

Gill flew to Mumbai to meet spinal injury specialist Dr. Abhay Nene. His medical report has been sent to BCCI chief selector Ajit Agarkar.

Also Read -Star player to get captaincy as Shubman Gill doubtful for South Africa ODIs

Gill Has a Nerve Injury

According to a report in The Times of India, Gill has a nerve injury. The team management does not want to rush his return because the T20 World Cup will be held in February–March next year. It is possible that Gill will not play again in 2025. He may return for the New Zealand series starting on January 11 next year.

When Will Gill Start Rehab?

Before starting rehab, Gill must take complete rest. It is unlikely he will be available for the five-match T20I series against South Africa. India will also play South Africa in three ODIs from November 30 after the Test series ends.

A BCCI source told PTI that “Gill has been given an injection to reduce his symptoms and will need a period of rest before starting rehab, training, and skill work. There is also a chance he may miss the T20I series.”